A number of deregulated genes with activating mutations or translocations for T-ALL have been described: FBXW7 (14%), TAL1 (30%), NOTCH1 (50%), CDKN2A (61%), and CDKN2B (58%) [194]. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.